Bionano Genomics' Special Meeting of Stockholders Update
On October 31, Bionano Genomics, Inc. (NASDAQ: BNGO) revealed important developments regarding its Special Meeting of Stockholders. The initial gathering was held on October 2 and was scheduled to reconvene on October 30. Unfortunately, a quorum was not reached, which necessitated the decision to postpone the meeting once again. Preliminary statistics indicated that only approximately 30.7% of the total shares outstanding had cast their votes by the time of the reconvened meeting, falling short of the required 33.3% needed for quorum.
New Date for the Special Meeting
The Special Meeting will now take place at 10 a.m. Pacific Time on November 27. Voting will remain open until 11:59 p.m. Eastern Time on November 26. Shareholders who previously submitted proxies should note that their votes will be counted during the reconvened meeting unless they have explicitly revoked them. Importantly, stockholders who have already cast their ballots need not take further action unless they wish to change their vote.
Voting Instructions for Stockholders
For those who have yet to cast their vote, Bionano encourages participation by reaching out via telephone. Stockholders can utilize the toll-free number 1-800-690-6903 to cast their votes. Detailed information regarding the proposals presented for stockholder approval, which includes the issuance of common stock upon warrant exercise, can be located in the company's definitive proxy statement filed with the Securities and Exchange Commission.
Importance of Participation
It is crucial for stockholders to review the definitive proxy statement thoroughly before making any voting decisions. The important details concerning the proposals and the specifics of the Special Meeting are outlined there. As Erik Holmlin, PhD, the CEO of Bionano, expressed gratitude for stockholder participation, he noted the importance of reaching quorum for the Company's ongoing plans and viability.
CEO's Comments on Stockholder Engagement
Dr. Holmlin acknowledged the contributions of the stockholders who engaged in the voting process and shared insights on the current voting landscape. He emphasized the need for additional votes, highlighting that approximately 2.2 million more votes are required to achieve quorum. This adjournment allows greater opportunity for stockholder involvement in this significant decision-making process.
About Bionano Genomics
Bionano Genomics is a trailblazer in the realm of genome analysis solutions, dedicated to transforming how researchers and clinicians understand biology and medicine. The company's mission is centered on advancing optical genome mapping (OGM) techniques to uncover novel insights in both basic and clinical research. Bionano provides a comprehensive range of OGM solutions applicable in various research settings.
Innovations and Services
In addition to OGM tools, Bionano specializes in offering industry-leading, platform-agnostic genome analysis software, as well as innovative nucleic acid extraction and purification services utilizing proprietary isotachophoresis technology. Their business segment, Lineagen, Inc. operating under Bionano Laboratories, further extends the offering of OGM-based diagnostic tests, helping to propel their vision in the field of genomic analysis.
Continuous Commitment to Research
Bionano’s commitment to pioneering genomic solutions positions it as a noteworthy player in the biogenomic space, meeting the evolving needs of researchers and practitioners. Their dedication to enhancing capabilities in genome visualization and interpretation is reflected in their innovative products and services.
Frequently Asked Questions
When is the rescheduled Special Meeting of Stockholders?
The rescheduled meeting is set for November 27 at 10 a.m. Pacific Time.
How can stockholders cast their vote?
Stockholders can vote by calling a toll-free number at 1-800-690-6903.
What proposals will be voted on during the Special Meeting?
The proposals include stockholder approval for the issuance of common stock upon the exercise of warrants.
Why was the Special Meeting adjourned?
The meeting was adjourned due to a lack of quorum, with only 30.7% of shares voted.
What is Bionano Genomics’ mission?
Bionano Genomics aims to transform genome analysis through optical genome mapping and innovative diagnostic solutions.
